Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

1.6K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.6K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

1.7K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.7K
Disorders of Leukocytes01:27

Disorders of Leukocytes

1.5K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.5K
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

2.2K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
2.2K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

1.5K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.5K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

2.5K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fecal Microbiota Transplant in Parkinson's Disease: Insights into the Gut-Brain Axis and the Challenge of Sustained Response.

Annals of neurology·2026
Same author

Workplace Lactation in Neurology: Barriers and Opportunities.

Neurology. Clinical practice·2026
Same author

Prebiotic intervention changes host and microbe proteomes in plasma extracellular vesicles of Parkinson's disease.

Scientific reports·2026
Same author

Essential tremor-like phenotype in Fragile X carrier women.

Clinical parkinsonism & related disorders·2026
Same author

Validity of a Wearable Digital Insole for Assessing Gait ON and OFF in Parkinson's Disease.

Annals of clinical and translational neurology·2026
Same author

Recruitment strategies for the racial disparities in Parkinson's disease study: Partnering with patients from the Black community.

Parkinsonism & related disorders·2026
Same journal

Cardiac Sympathetic Neuroimaging in Autonomic Synucleinopathies: <sup>123</sup>I-Metaiodobenzylguanidine and <sup>18</sup>F-Dopamine.

Movement disorders clinical practice·2026
Same journal

Acetazolamide-Responsive Exertion-Triggered Episodic Ataxia in DHDDS-Related Congenital Disorder of Glycosylation.

Movement disorders clinical practice·2026
Same journal

Epileptic-Dyskinetic Encephalopathy in Snijders Blok-Campeau Syndrome: Expanding the Phenotypic Spectrum.

Movement disorders clinical practice·2026
Same journal

Hardware Sophistications in Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease; Is the Juice Worth the Squeeze?

Movement disorders clinical practice·2026
Same journal

Correction to "Advancing Neuromodulation for Functional Movement Disorders: A Contemporary Narrative Review of Evidence, Gaps, and Future Outlook".

Movement disorders clinical practice·2026
Same journal

Efficacy of IncobotulinumtoxinA (BoNT-A) Injections in Upper Limb Task-Specific and Position-Dependent Tremors.

Movement disorders clinical practice·2026
See all related articles

Related Experiment Video

Updated: Nov 18, 2025

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

10.0K

Movement Disorders and Hematologic Diseases.

Roshni Abee Patel1, Deborah A Hall1, Sheila Eichenseer2

  • 1Department of Neurological Sciences Rush University Medical Center Chicago Illinois USA.

Movement Disorders Clinical Practice
|February 8, 2021
PubMed
Summary
This summary is machine-generated.

Hematologic abnormalities can cause movement disorders. This review aids clinicians in recognizing and treating these conditions, emphasizing basic lab tests for diagnosis.

Keywords:
movement disorders, hematology, anemia, acanthocytes, thrombocytopenia

More Related Videos

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

12.0K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.5K

Related Experiment Videos

Last Updated: Nov 18, 2025

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

10.0K
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

12.0K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.5K

Area of Science:

  • Neurology
  • Hematology

Background:

  • Movement disorders can stem from or be linked to hematological abnormalities.
  • Early recognition and treatment are crucial for patient outcomes.

Purpose of the Study:

  • To guide clinicians in identifying and managing movement disorders associated with blood conditions.
  • To provide an educational overview of the relationship between hematology and neurology.

Main Methods:

  • A literature search using Medical Subject Headings (MeSH) terms for movement disorders and hematologic diseases.
  • A narrative, educational review approach was employed.

Main Results:

  • Conditions were categorized by hematologic type: red blood cell, white blood cell, clotting/bleeding disorders, and hematologic malignancies.
  • Identified conditions highlight the diverse impact of blood disorders on neurological function.

Conclusions:

  • Enhanced understanding of movement disorders linked to hematologic abnormalities.
  • Basic hematologic tests like complete blood count (CBC) and peripheral blood smear are vital for assessment.
  • Timely diagnosis and treatment, particularly for underlying malignancy or vitamin deficiency, can be curative.